Guardant Health Inc (NASDAQ: GH) kicked off on Tuesday, down -2.19% from the previous trading day, before settling in for the closing price of $35.62. Over the past 52 weeks, GH has traded in a range of $15.81-$38.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 49.27%. While this was happening, its average annual earnings per share was recorded 19.46%. With a float of $117.85 million, this company’s outstanding shares have now reached $123.16 million.
Let’s determine the extent of company efficiency that accounts for 1779 employees. In terms of profitability, gross margin is 81.07%, operating margin of -74.41%, and the pretax margin is -74.02%.
Guardant Health Inc (GH) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.61%, while institutional ownership is 103.02%. The most recent insider transaction that took place on Dec 13 ’24, was worth 81,200. In this transaction Director of this company sold 2,320 shares at a rate of $35.00, taking the stock ownership to the 2,676 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director proposed sale 2,320 for $35.00, making the entire transaction worth $81,200.
Guardant Health Inc (GH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 19.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Take a look at Guardant Health Inc’s (GH) current performance indicators. Last quarter, stock had a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.24, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.97 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Looking closely at Guardant Health Inc (NASDAQ: GH), its last 5-days average volume was 1.43 million, which is a drop from its year-to-date volume of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 20.70%. Additionally, its Average True Range was 1.56.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 79.93%, which indicates a significant increase from 14.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.23% in the past 14 days, which was lower than the 61.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.20, while its 200-day Moving Average is $25.62. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $35.58. Second resistance stands at $36.32. The third major resistance level sits at $36.85. If the price goes on to break the first support level at $34.31, it is likely to go to the next support level at $33.78. Should the price break the second support level, the third support level stands at $33.04.
Guardant Health Inc (NASDAQ: GH) Key Stats
The company with the Market Capitalisation of 4.30 billion has total of 123,555K Shares Outstanding. Its annual sales at the moment are 563,950 K in contrast with the sum of -479,450 K annual income. Company’s last quarter sales were recorded 191,480 K and last quarter income was -107,750 K.
